Januvia IP an under-the-radar catalyst for Merck (MRK) - Evercore ISI Mar 9, 2021 11:59AM
Evercore ISI Starts Atea Pharmaceuticals (AVIR) at Outperform Nov 25, 2020 08:08AM
Evercore ISI Starts Arcus Biosciences (RCUS) at Outperform Nov 23, 2020 07:45AM
Evercore ISI Upgrades Amgen (AMGN) to Outperform Jan 21, 2020 09:15AM
Evercore ISI Starts Phathom Pharmaceuticals (PHAT) at Outperform Nov 19, 2019 08:27PM
View Older Stories

Aug 26, 2019 09:24AM Evercore's former famed biotech analyst Mark Schoenebaum has passed away
Aug 7, 2019 10:03AM Evercore ISI Downgrades Teva Pharma (TEVA) to In Line
Jul 2, 2019 03:43AM UPDATE: Evercore ISI Upgrades Dova Pharmaceuticals Inc (DOVA) to Outperform
Jun 18, 2019 01:17PM UPDATE: Allergan (AGN) Sees Mid-Day Gains
Feb 6, 2019 08:47AM Macrogenics (MGNX) Could Trade to $2B+ Valuation - Evercore ISI
Jan 28, 2019 08:20AM Evercore ISI Downgrades Amgen (AMGN) to In Line
Jan 7, 2019 08:03AM Ravi Mehrotra Joins Evercore ISI Research Team
Nov 15, 2018 04:24PM Evercore ISI Starts Molecular Templates (MTEM) at Outperform
Oct 9, 2018 04:30PM Evercore ISI Recognized as the Top Ranked Independent Firm in U.S. Equity Research
Aug 24, 2018 08:40AM Pre-Open Movers 08/24: (ADSK) (SPLK) (BKE) (NFLX) Higher; (HIBB) (GPS) (ROST) Lower (more...)
Aug 24, 2018 08:14AM Evercore ISI Upgrades Mylan (MYL) to Outperform
Aug 13, 2018 03:23PM Teva Pharma (TEVA) Confident in Branded Business Trends, No Plans to Raise Equity - Evercore ISI
Aug 10, 2018 08:36AM Celgene (CELG) PT Lowered to $112 at Evercore ISI, Keeps 'Outperform'
Aug 7, 2018 10:05AM Formulary Update Positive for Mylan (MYL) - Evercore ISI
Jul 12, 2018 08:20AM News on Novartis' Gilenya Patents Positive for Celgene (CELG) - Evercore ISI
Jul 5, 2018 05:22PM Celgene's (CELG) EU Revlimid Settlement Slightly Below Expectations - Evercore ISI
Jun 21, 2018 04:40PM Amgen (AMGN) Aimovig TRx Overstated IMS Says - Evercore ISI
Jun 14, 2018 07:49AM Gilead Sciences (GILD) on Watch Following GSK Ph 3 GEMINI Trials
May 30, 2018 06:25PM Evercore ISI Starts MacroGenics (MGNX) at Outperform
May 22, 2018 01:19PM Evercore ISI Sees Under the Radar Driver for Jazz Pharmaceuticals (JAZZ)
May 14, 2018 01:01PM Celgene (CELG) Revlimid Discussed by HHS Secretary Azar - Evercore ISI
May 1, 2018 03:26PM Evecore ISI Doesn't Think Merck (MRK) KN-407 Failed
Apr 30, 2018 01:08PM UPDATE: Celgene (CELG) metabolite controversy is overdone - Evercore ISI
Apr 20, 2018 12:53PM UPDATE: Dicerna Pharmaceuticals (DRNA) PT Raised to $17 at Evercore ISI Amid Settlement
Apr 2, 2018 11:54AM UPDATE: Evercore ISI Downgrades Alkermes (ALKS) to In Line
Mar 19, 2018 08:08AM Evercore ISI Starts Pieris Pharmaceuticals (PIRS) at Outperform
Mar 13, 2018 04:30PM Medicines Co. (MDCO) Provides Important Update on Ph 3 RNAi Program - Evercore ISI
Mar 12, 2018 08:41AM ODYSSEY Results Seen as Positive for Medicines Co. (MDCO)
Mar 9, 2018 07:37AM UPDATE: Evercore ISI Starts miRagen Therapeutics (MGEN) at Outperform
Mar 8, 2018 12:33PM Jazz Pharmaceuticals (JAZZ) Xyrem Competitor Delayed - Evecore ISI
Feb 8, 2018 08:32AM Teva Pharma (TEVA) Leaving Room for Upside Surprise in EBITDA Guidance - Evercore ISI
Jan 16, 2018 05:57AM UPDATE: Evercore ISI Starts Dicerna Pharmaceuticals (DRNA) at Outperform; Alnylam Case Appears Favorable
Dec 21, 2017 08:50AM Biogen (BIIB) Defended at Evercore ISI; BAN-2401 Data Should Not Move Stock
Dec 20, 2017 10:19AM Mylan (MYL) Positioned for Possible Late 2019/2010 Launch of Glargine - Evercore ISI (SNY)
Dec 4, 2017 07:47AM Evercore ISI Starts Apellis Pharmaceuticals (APLS) at Outperform
Dec 1, 2017 08:14AM Valeant Pharma (VRX) in 'Very Good Shape' on Debt Covenants - Evercore ISI's Raffat
Nov 22, 2017 10:23AM GSK (GSK) Not Trying to Break Price in HIV with Dulo, Positive for Gilead Sciences (GILD) - Evercore ISI Raffat
Nov 10, 2017 01:15PM Everore ISI's Raffat Provides Takeaways on Juno Therapeutics (JUNO) ROCKET Trial Data (GILD)
Nov 1, 2017 10:34AM Allergan (AGN) Should Be Up - Evercore ISI's Raffat
Oct 25, 2017 11:17AM Teva Pharma (TEVA) Files Lawsuit Versus Eli Lilly (LLY) Related to CGRP Mab - Evercore ISI
Oct 10, 2017 05:19PM Evercore ISI named #3 in U.S. Equity Research by Institutional Investor's All-America Equity Research Survey
Oct 6, 2017 10:41AM UPDATE: Biogen (BIIB), Roche on Watch Amid Potential New PML case on Ocrevus
Sep 22, 2017 08:22AM Too Much 'Confusion and Nervousness' in Allergan (AGN) - Evercore ISI
Sep 21, 2017 03:59PM Express Scripts (ESRX) CMO Issues Blog on CAR-Ts and Gene Therapies
Sep 8, 2017 02:12PM Allergan (AGN) Legal Move 'Extremely Important for Industry' - Evercore ISI Raffat
Aug 9, 2017 09:32AM Evecore ISI's Raffat sees ~$29/sh valuation floor on Mylan (MYL) on the new guidance
Jul 25, 2017 08:00AM Josh Schimmer Joins Evercore ISI Research Team
Jun 29, 2017 04:29PM UPDATE: Evercore ISI Starts Dermira (DERM) at Outperform; Street Underestimating Acne Phase 3 Success
Jun 26, 2017 12:26PM Valeant Pharma (VRX) Gains Tied to Speculation of Debt-for-Equity Swap - Evercore ISI's Raffat
Jun 13, 2017 11:57AM Amgen (AMGN): ICER intends to lower the value-based price benchmark for Repatha - Evercore ISI
View Older Stories